Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
P. Jain, J. Gutierrez Bugarin, A. Guha, C. Jain, N. Patil, T. Shen, I. Stanevich, V. Nikore, K. Margolin, M. Ernstoff, V. Velcheti, J. Barnholtz-Sloan, A. Dowlati
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States'. Together they form a unique fingerprint.